Request Sample Inquiry
Allergy Diagnostics Market

Allergy Diagnostics Market

Allergy Diagnostics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

150

Base Year:

2021

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1367

Segments Covered
  • By Product & Service Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, Services, Other Instruments
  • By Allergen Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens
  • By Test Type In Vivo Tests, Skin Prick Tests, Patch Tests, In Vivo Tests, Other In Vitro Tests
  • By End User Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: 4,821.90 USD Million
Revenue 2028Revenue 2028: 8,873.68 USD Million
Revenue CAGRRevenue CAGR (2022 - 2028): 10.70%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Allergy Diagnostics Market Share

Allergy Diagnostics Market

Market Synopsis:

Global Allergy Diagnostics market is valued at 4,821.90 USD Million in 2021 and is projected to reach a value of 8,873.68 USD Million by 2028 at a CAGR of 10.70% over the forecast period. The increasing environmental pollution globally and the increasing access to healthcare insurance are estimated to enhance the growth of the Allergy Diagnostics market. Moreover, the Allergy Diagnostics market is expected to witness the highest growth during the forecast period owing to the high incidence of allergic diseases and associated heavy economic burden, and increasing funds by the organizations in the Allergy Diagnostics. The hazardous changes in the lifestyle of the population like the preference for junk food in the diet and increasing pollution are the other major factors driving the growth of the global Allergy Diagnostics market in the coming years. Furthermore, food allergies are showing the fastest growth nowadays due to the ignorance among individuals towards a healthy diet which is expected to increase the demand for Allergy Diagnostics during the forecast period. The utilization of mHealth in allergy diagnosis is the major factor driving the growth of the market during the forecast period. Furthermore, the latest diagnostic strategies for allergies and the research and analysis on new treatment approaches are presumed to be the key opportunities in the Allergy Diagnostics market in the upcoming years. The development of advanced technology indicates the great opportunity for growth of the Allergy Diagnostics market by introducing various types of blood tests in order to reduce further health issues. The rapidly changing lifestyle and the consumption of junk food especially among youngsters are driving the growth of the global Allergy Diagnostics market in the coming years.

Allergy Diagnostics Market Size, 2021 To 2028 (USD 8,873.68 Million)

Market Segmentation:

The Allergy Diagnostics market is segmented on the basis of product and services, allergen, test type, and end-user. On the basis of product and services, the market is segmented as Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, other Instruments, and Services. Based on Allergen, the market is segmented as, Inhaled Allergens, Food Allergens, Drug Allergens, and other Allergens. On the basis of test-type, the market is segmented as In Vivo Tests, Skin Prick Tests, Patch Tests, Other In Vivo Tests, and In Vitro Tests. By end-user, the market is segmented as Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, and Other End Users.

Below tree is interactive. You can click the nodes to get more information.

Consumable’s segment is projected to hold the largest share of the Allergy Diagnostics market in 2021

The consumables sector in the product and services segment is accounted to hold the largest share of the Allergy Diagnostics market during the year 2021. The growth of the consumables segment is mainly attributed to the increasing cases of allergies and the requirement of rapid tests in order to diagnose allergic conditions. The demand of the consumable segment has increased during the forecast period due to the arrival of covid-19 and significantly witness growth in the product and services segment.

In Vivo, tests are projected to acquire the largest share of the Allergy Diagnostics market during the forecast period

The In Vivo test type segment in the test type sector is accounted to hold the largest share of the Allergy Diagnostics market during the forecast period. The growth of In Vivo tests is primarily attributed to the increasing adoption of various tests in the Vivo tests segment such as skin prick tests. Moreover, these tests are safe convenient, dependable, and cost-effective and it is expected to increase the demand for Vivo tests in the coming years.

North America is expected to acquire the largest share of the Allergy Diagnostics market in the year 2021

The largest share of North America is primarily attributed to favorable reimbursement scenarios for the allergy diagnosis, availability of support and initiative by the associations, and rising incidence of allergies. The good healthcare infrastructure and advanced diagnostic technology in the region are increasing the demand for the Allergy Diagnostics market in North America.

In Asia the Allergy Diagnostics market is projected to witness the highest growth by the year 2024 owing to the developing healthcare infrastructures, increase in disposable income, increasing prevalence of allergic diseases, and increasing aging population in the region. Moreover, the increasing population and growth in the economies in developing countries like India, Japan, and China are projected to drive the growth of the Allergy Diagnostics market in Asia.

Some of the latest trends that are observed in the global Allergy Diagnostics market are the rising number of partnerships and collaborations, a growing number of mergers and acquisitions, increasing research and development activities, and new product launches which are expected to enhance the market growth in the upcoming years.

Competitive Landscape:

The major key players present in the Allergy Diagnostics market are adopting various strategies such as collaborations, new product launches, acquisitions, and expansions to increase the market share. The prime key players in the Allergy Diagnostics market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), Romer Labs Division Holding (Austria), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Minaris Medical America, Inc. (the US), and Erba Group (UK).

Allergy Diagnostics Market is segmented as follows:

Parameter Details
Segments Covered
  • Product & Service (Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, Services, Other Instruments)
  • Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens)
  • Test Type (In Vivo Tests, Skin Prick Tests, Patch Tests, In Vivo Tests, Other In Vitro Tests)
  • End User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Thermo Fisher Scientific Inc.
  • (US)
  • Siemens Healthineers (Germany)
  • Danaher (US)
  • Omega Diagnostics Group PLC (UK)
  • bioMérieux SA (France)
  • Romer Labs Division Holding (Austria)
  • EUROIMMUN Medizinische Labordiagnostika AG (Germany)
  • HollisterStier Allergy (US)
  • NEOGEN Corporation (US)
  • Eurofins Scientific (Luxembourg)
  • Minaris Medical America Inc. (US)
  • Stallergenes Greer (UK)
  • HOB Biotech Group Corp. Ltd. (China)
  • HYCOR Biomedical (US)
  • R-Biopharm AG (Germany)
  • AESKU.GROUP GmbH (Germany)
  • ACON Laboratories Inc. (US)
  • Lincoln Diagnostics Inc. (US)
  • Astra Biotech GmbH (Germany)
  • and Erba Group (UK).
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Allergy Diagnostics Market is tabulated as follows:

Allergy Diagnostics Market to Reach Valuation of 8,873.68 USD Million by 2028; Increasing Environmental Pollution is Driving the Market”
In terms of revenue, the Global Allergy Diagnostics Market is expected to reach 8,873.68 USD Million by 2028, growing at a CAGR of 10.70% from 2022 to 2028. The high prevalence of allergic diseases and related heavy economic burden, increasing environmental pollution levels, rising funds by associa...
FAQ
Frequently Asked Question
  • The global Allergy Diagnostics valued at 4,821.90 USD Million in 2020 and is expected to reach 8,873.68 USD Million in 2028 growing at a CAGR of 10.70%.

  • The prominent players in the market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK)..

  • The market is project to grow at a CAGR of 10.70% between 2021 and 2028.

  • The driving factors of the Allergy Diagnostics include

    • increasing environmental pollution globally and the increasing access to healthcare insurance

  • North America was the leading regional segment of the Allergy Diagnostics in 2020.